Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Aytu BioScience Inc
AYTUCurrent price
2.24 USD
-0.01 USD (-0.44%)
Last closed
2.2 USD
Company
aytubio.com
ISIN
US0547548745
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ
Capitalization
14 450 126 USD
Yield for 12 month
-22.76 %
1Y
3Y
5Y
10Y
15Y
AYTU
Aytu Biopharma, Inc., a pharmaceutical company, focuses on commercializing novel therapeutics drugs in the United States and internationally. The company offers prescription products for the treatment of attention deficit hyperactivity disorder (ADHD), including Adzenys XR-ODT for patients from six years of age and above, and Cotempla XR-ODT for patients from six to seventeen years old. It also provides pediatric prescription product portfolio comprising Karbinal ER, an extended-release carbinoxamine (antihistamine) suspension indicated to treat numerous allergic conditions for patients two years and above; and Poly-Vi-Flor and Tri-Vi-Flor complementary prescription fluoride-based multi-vitamin products containing combinations of fluoride and vitamins in liquid and chewable tablet form for infants and children with fluoride deficiency. The company was formerly known as Aytu BioScience, Inc. and changed its name to Aytu Biopharma, Inc. in March 2021. Aytu Biopharma, Inc. is headquartered in Denver, Colorado. Address: Denver Corporate Center III, Denver, CO, United States, 80237
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
8 USDP/E ratio
–Dividend Yield
–Current Year
+81 002 000 USD
Last Year
+107 399 000 USD
Current Quarter
+17 976 000 USD
Last Quarter
+17 993 000 USD
Current Year
+54 586 000 USD
Last Year
+66 632 000 USD
Current Quarter
+11 906 000 USD
Last Quarter
+11 693 000 USD
Key Figures AYTU
1 year
3 years
5 years
10 years
EBITDA
6 113 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-1.06 %
PEG Ratio
–
Return On Equity TTM
-47.24 %
Wall Street Target Price
8 USD
Revenue TTM
81 002 000 USD
Book Value
4.64 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-41.5 %
Dividend Yield
–
Gross Profit TTM
66 632 000 USD
Earnings per share
-2.86 USD
Diluted Eps TTM
-2.86 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
-19.56 %
Dividend Analytics AYTU
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History AYTU
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:20
Payout Ratio
–
Last Split Date
06.01.2023
Dividend Date
09.12.2020
Stock Valuation AYTU
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
10.2145
Enterprise Value Revenue
0.1182
Price Sales TTM
0.1784
Enterprise Value EBITDA
1.1412
Price Book MRQ
0.5214
Financials AYTU
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators AYTU
For 52 weeks
2.2 USD
3.5 USD
50 Day MA
2.49 USD
Shares Short Prior Month
324 028
200 Day MA
2.82 USD
Short Ratio
19.31
Shares Short
315 880
Short Percent
6.42 %
BeatStart